Topical Timolol 0.5% Gel-Forming Solution for Small Deep Facial Infantile Hemangiomas

Authors

  • Jennifer Sorrell M.D.,

    1. Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
    Search for more papers by this author
  • Sarah L. Chamlin M.D.

    Corresponding author
    1. Division of Pediatric Dermatology, Feinberg School of Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois
    • Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
    Search for more papers by this author

Address correspondence to Sarah L. Chamlin, M.D., Division of Pediatric Dermatology, Ann and Robert H. Lurie Children's Hospital of Chicago, 225 East Chicago Ave. Box 107, Chicago, IL 60611, or e-mail: schamlin@luriechildrens.org.

Abstract

We report three cases of successful treatment of proliferating deep infantile hemangiomas with topical timolol 0.5% gel-forming solution (GFS) used two to three times daily. We recommend considering timolol as an initial option for small, deep facial hemangiomas that are not causing functional compromise or complications but may have an unsatisfactory cosmetic appearance. In our experience, albeit limited, this is a safe alternative to watchful waiting.

Ancillary